• Jonathan Rubin (University of Pittsburgh, Mathematics)

    Zoom

    Geometric Mechanisms of Temporal Variability and Precision in Transient Biological Dynamics Understanding transient temporal effects—when events occur and how variable their timing is—represents a central challenge across biological systems. While traditional analyses often focus on steady-state behaviors and average frequencies, the response variability and timing precision observed in real biological systems demand a deeper understanding

  • Quindel Jones (UF Laboratory for Systems Medicine)

    423 Little Hall

    Mechanistic Models as Hypotheses: Integrating Structure and Data from Sickle Cell Disease to Bacterial Infection Mechanistic models gain scientific value when treated as testable hypotheses rather than fixed descriptions of biology. I illustrate this idea through two modeling studies that differ sharply in how biology and data shape mechanistic structure. I begin with my work

  • Wenrui Hao (Pennsylvania State University, Mathematics)

    Zoom

    A Data-Driven Computational Framework for Identifiability and Nonlinear Dynamics Discovery in Complex Systems Data-driven modeling is essential for deciphering complex biological systems, yet its utility is often constrained by two fundamental hurdles: the inability to guarantee parameter identifiability and the high computational cost of learning nonlinear dynamics. This talk introduces a unified computational framework designed

  • Mark Lewis (University of Victoria, Mathematics and Statistics)

    Zoom

    One equation helps solve three paradoxes in the spatial ecology of predators and prey In this talk I will introduce three paradoxes in the spatial ecology of predators and prey (1) Buffer Zone Paradox: Why do wolves maintain stable buffer zones for prey, even though they may be only saving prey for the neighboring packs?

  • David Basanta Gutierrez (Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center & Research Institute)

    Zoom

    Integrated Mathematical Modeling of Cancer - Modeling the ecology and evolution of cancer and treatment resistance We present a suite of hybrid agent-based models (ABMs) that integrate discrete cell-level dynamics with continuous microenvironmental signaling to study eco-evolutionary processes in cancer. Our 2D on-lattice framework couples agent behaviors—proliferation, mutation, and selection—with reaction-diffusion equations governing cytokine fields

  • Erica J. Graham (Bryn Mawr College, Mathematics)

    Zoom

    Modeling GLP-1 Treatments in Ovulatory Dysfunction GLP-1 receptor agonists (GLP-1 RAs) have gained widespread attention for their effectiveness in treating metabolic abnormalities such as type 2 diabetes and obesity. Central to their success is the regulation of glucose-insulin metabolism and improvement of insulin resistance. In reproductive endocrinology, GLP-1 RAs have also shown promise as off-label

  • Qing Han (Augusta University, Mathematics)

    Zoom

    Pertussis transmission models and demographic shifts under evolving vaccination programs Pertussis, a highly contagious infection of the respiratory tract, was one of the main causes of child morbidity and mortality in developed countries, in the pre-vaccine era. Following the scale-up and roll-out of childhood vaccination programs in the 1940s–1960s, the incidence and severity of pertussis

  • B. Sagar (University of Central Florida, Mathematics)

    Zoom To obtain the Zoom link, please contact Hemaho Taboe at hemahobeaugtaboe@ufl.edu or Calistus Ngonghala at calistusnn@ufl.edu.

    Dynamics of a two-stage epidemiological model with post-infection mortality and transmission heterogeneity   Many infectious diseases exhibit stage-structured progression (e.g., Influenza and COVID-19). This motivates us to formulate a two-stage epidemiological model that incorporates key post infection features, including reinfection and post-infection mortality (PIM). The model emphasizes the role of transmission heterogeneity in shaping disease

  • Hannah G. Anderson (Moffitt)

    Robust schedules of adoptive cell therapy in a virtual murine cohort of bladder cancer with experimental validation Even under the same treatment, responses can vary. Virtual cohorts build on an available, often limited, dataset to capture these differences and enable the discovery of treatment protocols that work well for a wide variety of individuals. In